[Bortezomib-induced eruption: Sweet syndrome? Two case reports].

Abstract

BACKGROUND Bortezomib (Velcade) is a proteasome inhibitor used in the treatment of myeloma and other blood dyscrasias. We report the cases of two patients who developed a peculiar toxic rash suggestive of Sweet's syndrome while receiving bortezomib; one patient also presented giant mucous membrane ulcerations. PATIENTS AND METHODS Case 1: bortezomib… (More)
DOI: 10.1016/j.annder.2008.10.039

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.